We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

73 hedge funds and large institutions have $735M invested in Sage Therapeutics in 2014 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 26 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 6

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

160% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 10

40% more funds holding

Funds holding: 52 → 73 (+21)

23% more capital invested

Capital invested by funds: $596M → $735M (+$140M)

Holders
73
Holders Change
+21
Holders Change %
+40.38%
% of All Funds
1.95%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
28
Increased
26
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BFA
BlackRock Fund Advisors
California
+$11.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$7.09M
3
JP Morgan Chase
JP Morgan Chase
New York
+$4.45M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$4.03M
5
Stifel Financial
Stifel Financial
Missouri
+$3.74M

Top Sellers

1
DM
Deerfield Management
New York
-$7.01M
2
PA
Perceptive Advisors
New York
-$5.15M
3
O
OrbiMed
New York
-$4.66M
4
Millennium Management
Millennium Management
New York
-$2.52M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
FSA
76
Franklin Street Advisors
North Carolina
– -$241K -7,650 Closed
CSS
77
Cubist Systematic Strategies
Connecticut
– -$217K -6,895 Closed
TRCT
78
Tower Research Capital (TRC)
New York
– -$9.39K -252 Closed
1 2 3
4

SAGE Hedge Fund Activity: Q4 2014 in Review

73 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q4 2014, worth a combined $735M — up 23% from $596M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new SAGE positions and 6 closed out — a net gain of 22 holders — while 26 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $11.9M. The largest seller was Deerfield Management, cutting an estimated $7.01M.

  • 73 institutional investors held Sage Therapeutics (SAGE) as of Q4 2014, up from 52 in Q3 2014.
  • Funds reported $735M of Sage Therapeutics stock for Q4 2014, up 23% quarter-over-quarter.
  • 28 funds opened new Sage Therapeutics positions in Q4 2014 and 6 closed out, a net change of +22 holders.
  • The largest Sage Therapeutics buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $11.9M added.
  • The largest Sage Therapeutics seller in Q4 2014 was Deerfield Management, an estimated $7.01M sold.

Based on aggregated 13F filings for Q4 2014.